Interesting Engineering on MSN3d
FDA approves first-ever rapid-acting insulin biosimilar for diabetes treatment
The FDA has approved Merilog, the first-ever rapid-acting insulin biosimilar for diabetes treatment that helps manage blood ...
Monthly Prescribing Reference3d
FDA Approves Merilog, a Rapid-Acting Insulin Biosimilar Product
Insulin-aspart-szjj is the first rapid-acting insulin biosimilar approved and the third insulin product approved by the FDA.
Medscape4d
FDA Okays New Rapid-Acting Biosimilar Insulin for Diabetes
The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog ...
pharmaphorum4d
First biosimilar fast-acting insulin reaches US market
The biosimilars reach the US market as the US insulin space has seen seismic changes in the last few years, with a clamour of ...
FDA approves first rapid-acting insulin biosimilar for patients with diabetes
Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...
FDA Approves Sanofi's Merilog As First Rapid-Acting Insulin Biosimilar Product For Diabetes
Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.
U.S. News & World Report2d
FDA Approves First Rapid-Acting Insulin Biosimilar for Patients With Diabetes
FDA Approves First Rapid-Acting Insulin Biosimilar for Patients With ... Both a 3-mL single-patient-use prefilled pen and a 10-mL multiple-dose vial are included in this approval.
MedPage Today7d
FDA OKs First Rapid-Acting Insulin Biosimilar for Diabetes
The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...
Sierra Sun Times4d
FDA Approves Merilog, First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes
Mariposa California's original daily updated online newspaper is the premier site for news and information on Yosemite, ...
KTEN3d
FDA Approves First Rapid-Acting Insulin Biosimilar for Patients With Diabetes
Merilog is a rapid-acting human insulin analog and the first rapid-acting ... Both a 3-mL single-patient-use prefilled pen and a 10-mL multiple-dose vial are included in this approval.